182 related articles for article (PubMed ID: 11325480)
1. Metabolic genetic polymorphisms and susceptibility to lung cancer.
Bouchardy C; Benhamou S; Jourenkova N; Dayer P; Hirvonen A
Lung Cancer; 2001 May; 32(2):109-12. PubMed ID: 11325480
[TBL] [Abstract][Full Text] [Related]
2. A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer.
Sachse C; Smith G; Wilkie MJ; Barrett JH; Waxman R; Sullivan F; Forman D; Bishop DT; Wolf CR;
Carcinogenesis; 2002 Nov; 23(11):1839-49. PubMed ID: 12419832
[TBL] [Abstract][Full Text] [Related]
3. Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer.
Nebert DW; McKinnon RA; Puga A
DNA Cell Biol; 1996 Apr; 15(4):273-80. PubMed ID: 8639263
[TBL] [Abstract][Full Text] [Related]
4. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens.
Le Marchand L; Sivaraman L; Pierce L; Seifried A; Lum A; Wilkens LR; Lau AF
Cancer Res; 1998 Nov; 58(21):4858-63. PubMed ID: 9809991
[TBL] [Abstract][Full Text] [Related]
5. Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes.
Thier R; Brüning T; Roos PH; Rihs HP; Golka K; Ko Y; Bolt HM
Int J Hyg Environ Health; 2003 Jun; 206(3):149-71. PubMed ID: 12872524
[TBL] [Abstract][Full Text] [Related]
6. Association of metabolic gene polymorphisms with tobacco consumption in healthy controls.
Smits KM; Benhamou S; Garte S; Weijenberg MP; Alamanos Y; Ambrosone C; Autrup H; Autrup JL; Baranova H; Bathum L; Boffetta P; Bouchardy C; Brockmoller J; Butkiewicz D; Cascorbi I; Clapper ML; Coutelle C; Daly AK; Muzi G; Dolzan V; Duzhak TG; Farker K; Golka K; Haugen A; Hein DW; Hildesheim A; Hirvonen A; Hsieh LL; Ingelman-Sundberg M; Kalina I; Kang D; Katoh T; Kihara M; Ono-Kihara M; Kim H; Kiyohara C; Kremers P; Lazarus P; Le Marchand L; Lechner MC; London S; Manni JJ; Maugard CM; Morgan GJ; Morita S; Nazar-Stewart V; Kristensen VN; Oda Y; Parl FF; Peters WH; Rannug A; Rebbeck T; Pinto LF; Risch A; Romkes M; Salagovic J; Schoket B; Seidegard J; Shields PG; Sim E; Sinnett D; Strange RC; Stucker I; Sugimura H; To-Figueras J; Vineis P; Yu MC; Zheng W; Pedotti P; Taioli E
Int J Cancer; 2004 Jun; 110(2):266-70. PubMed ID: 15069692
[TBL] [Abstract][Full Text] [Related]
7. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases.
Hein DW; Doll MA; Rustan TD; Gray K; Feng Y; Ferguson RJ; Grant DM
Carcinogenesis; 1993 Aug; 14(8):1633-8. PubMed ID: 8353847
[TBL] [Abstract][Full Text] [Related]
8. Expression and polymorphism of glutathione S-transferase in human lungs: risk factors in smoking-related lung cancer.
Nakajima T; Elovaara E; Anttila S; Hirvonen A; Camus AM; Hayes JD; Ketterer B; Vainio H
Carcinogenesis; 1995 Apr; 16(4):707-11. PubMed ID: 7728947
[TBL] [Abstract][Full Text] [Related]
9. Genetic factors in individual responses to environmental exposures.
Hirvonen A
J Occup Environ Med; 1995 Jan; 37(1):37-43. PubMed ID: 7620941
[TBL] [Abstract][Full Text] [Related]
10. Serum, plasma and paraffin-embedded tissues as sources of DNA for studying cancer susceptibility genes.
Blömeke B; Bennett WP; Harris CC; Shields PG
Carcinogenesis; 1997 Jun; 18(6):1271-5. PubMed ID: 9214613
[TBL] [Abstract][Full Text] [Related]
11. The role of individual susceptibility in cancer burden related to environmental exposure.
Bartsch H; Hietanen E
Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):569-77. PubMed ID: 8781385
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms of human N-acetyltransferase, cytochrome P450, glutathione-S-transferase, and epoxide hydrolase enzymes: relevance to xenobiotic metabolism and toxicity.
Wormhoudt LW; Commandeur JN; Vermeulen NP
Crit Rev Toxicol; 1999 Jan; 29(1):59-124. PubMed ID: 10066160
[TBL] [Abstract][Full Text] [Related]
13. Review of studies of selected metabolic polymorphisms and cancer.
d'Errico A; Malats N; Vineis P; Boffetta P
IARC Sci Publ; 1999; (148):323-93. PubMed ID: 10493265
[No Abstract] [Full Text] [Related]
14. Molecular epidemiology and urothelial cancer.
Tsukino H; Omori H; Kohshi K; Yamano Y; Katoh T
J UOEH; 2007 Sep; 29(3):265-89. PubMed ID: 17900006
[TBL] [Abstract][Full Text] [Related]
15. Putative susceptibility markers of coronary artery disease: association between VDR genotype, smoking, and aromatic DNA adduct levels in human right atrial tissue.
Van Schooten FJ; Hirvonen A; Maas LM; De Mol BA; Kleinjans JC; Bell DA; Durrer JD
FASEB J; 1998 Oct; 12(13):1409-17. PubMed ID: 9761785
[TBL] [Abstract][Full Text] [Related]
16. Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibility.
Daly AK; Cholerton S; Armstrong M; Idle JR
Environ Health Perspect; 1994 Nov; 102 Suppl 9(Suppl 9):55-61. PubMed ID: 7698086
[TBL] [Abstract][Full Text] [Related]
17. Detoxification enzymes: cellular metabolism and susceptibility to various diseases.
Silva M; Carvalho MDG
Rev Assoc Med Bras (1992); 2018 Apr; 64(4):307-310. PubMed ID: 30133607
[No Abstract] [Full Text] [Related]
18. Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility--a review.
Raunio H; Husgafvel-Pursiainen K; Anttila S; Hietanen E; Hirvonen A; Pelkonen O
Gene; 1995 Jun; 159(1):113-21. PubMed ID: 7607565
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetic profile of xenobiotic enzyme metabolism in survivors of the Spanish toxic oil syndrome.
Ladona MG; Izquierdo-Martinez M; Posada de la Paz MP; de la Torre R; Ampurdanés C; Segura J; Sanz EJ
Environ Health Perspect; 2001 Apr; 109(4):369-75. PubMed ID: 11335185
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms and oral cancer.
Taniyama Y; Takeuchi S; Kuroda Y
J UOEH; 2010 Sep; 32(3):221-36. PubMed ID: 20857816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
